Article metrics
PDF
Other content recommended for you
- Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study
- Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis
- Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis
- Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR
- Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
- Safety of ceftriaxone in paediatrics: a systematic review
- Adverse drug reactions in childhood: a review of prospective studies and safety alerts
- OHP-045 Incidence and risk factors of adverse drug reactions in the general population observed through an active pharmacovigilance project
- Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity
- Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia